Given that systemic sclerosis can affect their appearance, many people with the condition are open to dermocosmetic and…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A noninvasive imaging technique, which uses light to look at skin tissue over a wide area without actually touching it,…
Off-label treatment with JAK inhibitors appeared to keep lung function stable and reduce skin thickening, joint pain, and swelling in…
The use of immunosuppressive and combination treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) has increased…
Milk-derived extracellular vesicles — very small, natural particles from cow’s milk — were shown to safely reduce inflammation and scarring…
In people with diffuse cutaneous systemic sclerosis (dcSSc), certain skin features, including levels of specific molecules and cells, depend…
More than a third of adults with systemic sclerosis (SSc) who develop interstitial lung disease (ILD) see their condition…
Researchers in China have identified five genes — COL1A2, COL3A1, COL15A1, THY-1, and CCL19 — that may play a key…
Galderma is launching a Phase 2 clinical trial to test nemolizumab, an antibody the company is developing to ease…
Levels of certain types of immune cells are abnormally high in some people with systemic sclerosis (SSc), and this…